Mel Gibson Joins Fight Against Stem Cell Measure
By Paul Elias,
Associated Press
| 10. 31. 2004
The Proposition 71 race has turned into the battle of the Hollywood stars actor after Mel Gibson spoke out against the $3 billion bond measure for stem cell research and offered his help to the opposition campaign.
Gibson appeared on ABC's Good Morning America Thursday and said he had an "ethical problem" with the proposition, which would make about $300 million available annually for 10 years to fund the controversial research. The measure would allow cloning for medical research only. All told, including interest, it will cost $6 billion in taxpayer money over 30 years.
Gibson also has recorded a 60-second message that he gave to the campaign Thursday. A spokesman for the No on 71 campaign said officials are still discussing how to use the message, which they said arrived unexpectedly Thursday. A spokesman said the campaign already has produced two radio advertisements, which are airing throughout the state.
"It's kind of a last-minute thing but we are glad he could join," said No on 71 spokesman Tim Rosales. "He's a great spokesperson."
Gibson is the first Hollywood celebrity...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...